These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25963727)

  • 1. Metabolomic Analysis Reveals Increased Aerobic Glycolysis and Amino Acid Deficit in a Cellular Model of Amyotrophic Lateral Sclerosis.
    Valbuena GN; Rizzardini M; Cimini S; Siskos AP; Bendotti C; Cantoni L; Keun HC
    Mol Neurobiol; 2016 May; 53(4):2222-40. PubMed ID: 25963727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis.
    Cimini S; Rizzardini M; Biella G; Cantoni L
    J Neurochem; 2014 May; 129(3):413-25. PubMed ID: 24359187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism.
    D'Alessandro G; Calcagno E; Tartari S; Rizzardini M; Invernizzi RW; Cantoni L
    Neurobiol Dis; 2011 Aug; 43(2):346-55. PubMed ID: 21530659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis.
    Menzies FM; Cookson MR; Taylor RW; Turnbull DM; Chrzanowska-Lightowlers ZM; Dong L; Figlewicz DA; Shaw PJ
    Brain; 2002 Jul; 125(Pt 7):1522-33. PubMed ID: 12077002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress.
    Cookson MR; Menzies FM; Manning P; Eggett CJ; Figlewicz DA; McNeil CJ; Shaw PJ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):75-85. PubMed ID: 12215229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration induced by complex I inhibition in a cellular model of familial amyotrophic lateral sclerosis.
    Rizzardini M; Lupi M; Mangolini A; Babetto E; Ubezio P; Cantoni L
    Brain Res Bull; 2006 Apr; 69(4):465-74. PubMed ID: 16624679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The familial amyotrophic lateral sclerosis-associated A4V SOD1 mutant is not able to regulate aerobic glycolysis.
    de Holanda Paranhos L; Magalhães RSS; de Araújo Brasil A; Neto JRM; Ribeiro GD; Queiroz DD; Dos Santos VM; Eleutherio ECA
    Biochim Biophys Acta Gen Subj; 2024 Aug; 1868(8):130634. PubMed ID: 38788983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells.
    Rizzardini M; Mangolini A; Lupi M; Ubezio P; Bendotti C; Cantoni L
    J Neurol Sci; 2005 May; 232(1-2):95-103. PubMed ID: 15850589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis.
    Allen SP; Rajan S; Duffy L; Mortiboys H; Higginbottom A; Grierson AJ; Shaw PJ
    Neurobiol Aging; 2014 Jun; 35(6):1499-509. PubMed ID: 24439480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation to G93Asuperoxide dismutase 1 in a motor neuron cell line model of amyotrophic lateral sclerosis: the role of glutathione.
    Tartari S; D'Alessandro G; Babetto E; Rizzardini M; Conforti L; Cantoni L
    FEBS J; 2009 May; 276(10):2861-74. PubMed ID: 19459941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of nuclear factor-kappaB activation increased glutamate excitotoxicity in a motoneuron-neuroblastoma hybrid cell line expressing mutant (G93A) Cu/Zn-superoxide dismutase.
    Pyo JS; Ko YS; Kim WH; Kim M; Lee KW; Nam SY; Chung HY; Cho SJ; Baik TK; Lee BL
    J Neurosci Res; 2010 Aug; 88(11):2494-503. PubMed ID: 20623531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
    Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
    J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New links between SOD1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis.
    Bastow EL; Peswani AR; Tarrant DS; Pentland DR; Chen X; Morgan A; Staniforth GL; Tullet JM; Rowe ML; Howard MJ; Tuite MF; Gourlay CW
    J Cell Sci; 2016 Nov; 129(21):4118-4129. PubMed ID: 27656112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
    Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
    Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis.
    Veyrat-Durebex C; Corcia P; Piver E; Devos D; Dangoumau A; Gouel F; Vourc'h P; Emond P; Laumonnier F; Nadal-Desbarats L; Gordon PH; Andres CR; Blasco H
    Mol Neurobiol; 2016 Dec; 53(10):6910-6924. PubMed ID: 26666663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline Metabolism.
    Patin F; Corcia P; Vourc'h P; Nadal-Desbarats L; Baranek T; Goossens JF; Marouillat S; Dessein AF; Descat A; Madji Hounoum B; Bruno C; Leman S; Andres CR; Blasco H
    Mol Neurobiol; 2017 Sep; 54(7):5361-5374. PubMed ID: 27590138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.